Gene · 5566
Papers2,763
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,763
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Globo H ceramide confers chemoresistance and poor prognosis to advanced gallbladder cancer via A2AR/cAMP/PKA pathway. | Theranostics | 2026 | 41799195 | PubTator, text mining | PubMed |
| Application of a novel myristoylproteomics approach identifies GLIPR2 as a key pro-ferroptotic substrate in non-small cell lung cancer. | Mater Today Bio | 2026 | 41782991 | PubTator, text mining | PubMed |
| Timescale-dependent Phosphoproteomic Remodeling and Motility-associated Adaptation under Chronic Cabozantinib Exposure in Renal Cell Carcinoma. | Cancer Genomics Proteomics | 2026 | 41771580 | PubTator, text mining | PubMed |
| Defining the Active Conformation of Typical Protein Kinase Domains from Substrate-Bound PDB Structures Enables Active-State AlphaFold2 Models for All 437 Human Catalytic Protein Kinases. | bioRxiv | 2026 | 41757035 | PubTator, text mining | PubMed |
| Selective Inhibitor of Protein Kinase PKN3 Generated by Conjugation of a Structurally Optimized Bumped N-(2-Aminoethyl)-8-anilinoisoquinoline-5-sulfonamide (H-9) with d-Arginine-Rich Chain. | Molecules | 2026 | 41752364 | PubTator, text mining | PubMed |
| Correction: DNAJB1-PRKACA fusion protein-regulated LINC00473 promotes tumor growth and alters mitochondrial fitness in fibrolamellar carcinoma. | PLoS Genet | 2026 | 41746900 | PubTator, text mining | PubMed |
| Benchmarking EGF signaling pathway inference using phosphoproteomics and kinase-substrate interactions. | Nat Commun | 2026 | 41741430 | PubTator, text mining | PubMed |
| Molecular pathology of primary aldosteronism and hypercortisolism: Impact on adrenal surgery. | iScience | 2026 | 41736857 | PubTator, text mining | PubMed |
| Overcoming CXCR4-Mediated T-Cell Exclusion Potentiates Antitumor Cytotoxicity in Fibrolamellar Carcinoma. | Gastroenterology | 2026 | 41701126 | PubTator, text mining | PubMed |
| Optimization of potential targets for antidepressant Chinese medicines: AI and multi-omics methods. | Chin Med | 2026 | 41668206 | PubTator, text mining | PubMed |
| SLC6A6 imports taurine into mitochondria to sustain mitochondrial translation and tumour growth. | Nat Metab | 2026 | 41652173 | Swiss-Prot, curated | PubMed |
| Pyrimidine-containing natural products: occurrences and biological activities. | Nat Prod Bioprospect | 2026 | 41634209 | PubTator, text mining | PubMed |
| Contrastive learning in both structure and function spaces improve drug-target interaction prediction. | BMC Bioinformatics | 2026 | 41629789 | PubTator, text mining | PubMed |
| Covalent modification of a glutamic acid inspired by HaloTag technology. | Nat Commun | 2026 | 41617704 | PubTator, text mining | PubMed |
| Study on the Mechanism of Ku Diding in the Treatment of Diabetes based on Network Pharmacology, Molecular Docking Technology, and Molecular Dynamics. | Curr Comput Aided Drug Des | 2026 | 41603182 | PubTator, text mining | PubMed |
| Overexpression of GPER1 suppressed esophageal carcinoma growth via activating cAMP pathway. | Eur J Histochem | 2026 | 41586754 | PubTator, text mining | PubMed |
| Chai-shen powder treated perimenopausal syndrome through the PI3K-Akt/cAMP signaling pathway: integrated clinical analysis, network pharmacology, microRNA and animal experiment. | Climacteric | 2026 | 41379710 | PubTator, text mining | PubMed |
| Global Profiling of Lysine Ubiquitylation in the Human Hypothalamus. | Proteomics Clin Appl | 2026 | 41208143 | PubTator, text mining | PubMed |
| DNAJ-PKAc induces metabolic rewiring and enhanced glutamine flux in fibrolamellar HCC. | J Hepatol | 2026 | 41205756 | PubTator, text mining | PubMed |
| Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation of Mucuna pruriens for Parkinson's Disease Treatment. | Curr Drug Targets | 2026 | 41193453 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5566/papers?page=3